Neogenomics (NEO) EBT Growth (3y) (2013 - 2026)
Neogenomics (NEO) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -36.31% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.36% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -6.75% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 9.91% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 2.67% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 14.73% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -3.23% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 58.91% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -2.56% |
| 10 | Neogenomics | 1.48 Bn | 1.33 Bn | 80.86 Mn | 19.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.52% |
| Dec 31, 2025 | 21.37% |
| Sep 30, 2025 | 12.67% |
| Jun 30, 2025 | -3.74% |
| Mar 31, 2025 | 21.56% |
| Dec 31, 2024 | 28.54% |
| Sep 30, 2024 | 8.33% |
| Jun 30, 2024 | -31.21% |
| Mar 31, 2024 | -9.41% |
| Dec 31, 2023 | -59.01% |
| Sep 30, 2023 | -126.72% |
| Jun 30, 2023 | -14.05% |
| Mar 31, 2023 | -78.90% |
| Dec 31, 2022 | -131.97% |
| Sep 30, 2022 | -137.23% |
| Jun 30, 2022 | -175.65% |
| Mar 31, 2022 | -128.65% |
| Dec 31, 2021 | -222.46% |
| Sep 30, 2021 | -136.07% |
| Jun 30, 2021 | 366.69% |